Cyclosporin A in the treatment of myelodysplastic syndromes (MDS)

被引：0
|
作者：
Shirin, AD [1 ]
Volkova, MA [1 ]
机构：
[1] RUSSIAN ACAD MED SCI,CANC RES CTR,DEPT HEMATOL,MOSCOW,RUSSIA
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：416 / 416
页数：1
相关论文
共 50 条
  • [41] Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group
    Goetze, Katharina
    Platzbecker, Uwe
    Giagounidis, Aristoteles
    Haase, Detlef
    Luebbert, Michael
    Aul, Carlo
    Ganser, Arnold
    Germing, Ulrich
    Hofmann, Wolf-Karsten
    ANNALS OF HEMATOLOGY, 2010, 89 (09) : 841 - 850
  • [42] Need of transfusions, treatment and survival of patients with Myelodysplastic Syndromes (MDS): Update of the outpatient MDS registry
    Steinmetz, H. T.
    Boettger, I
    Lathan, B.
    Sauer, A.
    Severin, K.
    Germing, U.
    Schmitz, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 234 - 234
  • [43] Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group
    Katharina Götze
    Uwe Platzbecker
    Aristoteles Giagounidis
    Detlef Haase
    Michael Lübbert
    Carlo Aul
    Arnold Ganser
    Ulrich Germing
    Wolf-Karsten Hofmann
    Annals of Hematology, 2010, 89 : 841 - 850
  • [44] Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)
    Kasprzak, Annika
    Nachtkamp, Kathrin
    Gattermann, Norbert
    Germing, Ulrich
    CANCERS, 2022, 14 (08)
  • [45] THE VALUE OF SCORING SYSTEMS IN MYELODYSPLASTIC SYNDROMES (MDS)
    KRIEGER, O
    BERNHART, M
    KASPARU, H
    KOLLER, U
    NOWOTNY, H
    TUCHLER, H
    LUTZ, D
    BLUT, 1988, 56 (06): : C13 - C13
  • [46] Management of older adults with myelodysplastic syndromes (MDS)
    Luskin, Marlise R.
    Abel, Gregory A.
    JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (04) : 302 - 307
  • [47] Intensive chemotherapy with quinine in myelodysplastic syndromes (MDS).
    Wattel, E
    Solary, E
    Caillot, D
    Dreyfus, F
    Brion, A
    Mahe, B
    HoangNgoc, L
    Maloisel, F
    Guerci, A
    Rochant, H
    Gratecos, N
    Sadoun, A
    Stamatoullas, A
    Casassus, P
    Janvier, M
    Stoppa, AM
    Desablens, B
    Fegeux, N
    Ifrah, N
    Abgrall, JP
    Guyotat, D
    Dupriez, B
    Peny, AM
    Brice, P
    Pignon, B
    Leporrier, M
    Lepelley, P
    Fenaux, P
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 34 - 34
  • [48] In vitrodevelopment of haemopoietic progenitors in myelodysplastic syndromes (MDS)
    S Tauro
    DT Bowen
    SJL Brada
    JThM de Wolf
    DW Hendriks
    JW Smit
    E Vellenga
    Leukemia, 1999, 13 : 494 - 495
  • [49] INTENSIVE CHEMOTHERAPY FOR PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    BERNSTEIN, SH
    BRUNETTO, VL
    DAVEY, FR
    MAYER, RJ
    WURSTERHILL, D
    SCHIFFER, CA
    BLOOMFIELD, CD
    BLOOD, 1993, 82 (10) : A196 - A196
  • [50] MONOCYTE AND NEUTROPHIL FUNCTION IN MYELODYSPLASTIC SYNDROMES (MDS)
    NAGLER, A
    KLETTER, Y
    OBEDEANU, N
    TATARSKY, I
    EXPERIMENTAL HEMATOLOGY, 1986, 14 (06) : 549 - 549
12345